'''Marc Guy Albert Marie Lacroix''' [pronunciation: "mɑːk lakʁwa"] is a [[biochemist]] (educated at [[University of Liège]]) and a researcher (b: 28 April 1963 in [[Verviers]], [[Wallonia]], Belgium) who specializes in [[breast cancer]] biology, [[metastasis]] and therapy.<ref name="Siwek2">{{cite journal | first=B | last= Siwek | coauthors= Larsimont D, Lacroix M, Body JJ, | title= Establishment and characterization of three new breast-cancer cell lines | journal= International Journal of Cancer | year=1998 | volume=76 |pages=677–683 | pmid=9610725 | doi= 10.1002/(SICI)1097-0215(19980529)76:5<677::AID-IJC11>3.0.CO;2-1 | issue=5}}</ref><ref name="Lacroix8">{{cite journal | first=M | last= Lacroix | coauthors= Zammatteo N, Remacle J, Leclercq G. | title= A low-density DNA [[microarray]] for analysis of markers in breast cancer | journal= International Journal of Biological Markers | year=2002 | volume=17 |pages=5–23 | pmid=11936587 | issue=1}}</ref><ref name="Lacroix9">{{cite journal | first=M | last= Lacroix | coauthors= Leclercq G. | title= Relevance of breast cancer cell lines as models for breast tumours: an update | journal= [[Breast Cancer Research and Treatment (journal)|Breast Cancer Research and Treatment]] | year=2004 | volume=83 |pages=249–289 | pmid=14758095 | doi= 10.1023/B:BREA.0000014042.54925.cc | issue=3}}</ref><ref name="Lacroix12">{{cite journal | first=M | last= Lacroix | coauthors= Haibe-Kains B, Hennuy B, Laes JF, Lallemand F, Gonze I, Cardoso F, Piccart M, Leclercq G, Sotiriou C. | title= Gene regulation by phorbol 12-myristate 13-acetate in MCF-7 and MDA-MB-231, two breast cancer cell lines exhibiting highly different phenotypes | journal= Oncology Reports | year=2004 | volume=12 |pages=701–707 | pmid=15375488 | issue=4}}</ref><ref name="Lacroix13">{{cite journal | first=M | last= Lacroix | coauthors= Leclercq G, on behalf of BreastMed Consortium. | title= The "portrait" of hereditary breast cancer | journal= [[Breast Cancer Research and Treatment (journal)|Breast Cancer Research and Treatment]] | year=2005 | volume=89 |pages=297–304 | pmid=15754129 | doi= 10.1007/s10549-004-2172-4 | issue=3}}</ref><ref name="De Longueville1">{{cite journal | first=F | last= De Longueville | coauthors= Lacroix M (co-first author), Barbuto AM, Bertholet V, Gallo D, Larsimont D, Marcq L, Zammatteo N, Boffe S, Leclercq G, Remacle J. | title= Molecular characterization of breast cancer cell lines by a low-density microarray | journal= International Journal of Oncology | year=2005 | volume=27 |pages=881–892 | pmid=16142302 | issue=4}}</ref><ref name="Lacroix14">{{cite journal | first=M | last=Lacroix | coauthors= Toillon RA, Leclercq G. | title= P53 and breast cancer, an update | journal= Endocrine-Related Cancer | year=2006 | volume=13 |pages=293–325 |pmid=16728565 | doi= 10.1677/erc.1.01172 | issue=2}}</ref><ref name="Lacroix15">{{cite journal | first=M | last=Lacroix. | title= Significance, detection and markers of disseminated breast cancer cells | journal= Endocrine-Related Cancer | year=2006 | volume=13 |pages=1033–1067 |pmid=17158753 | doi= 10.1677/ERC-06-0001 | issue=4}}</ref><ref name="Lacroix16">{{cite journal | first=M | last=Lacroix. | title= Persistent use of "false" cell lines | journal= International Journal of Cancer | year=2008 | volume=122 |pages=1–4 |pmid=17960586 | doi= 10.1002/ijc.23233 | issue=1}}</ref>

He works at [[Institut Jules Bordet]] ([[Brussels]], Belgium). He lives in [[Baelen]]

== Earlier work ==
Breast cancer [[Cell (biology)|cells]] (BCC) frequently [[metastasis|metastasize]] to the [[skeleton]], where they lead to tumor-induced osteolysis and subsequent [[morbidity]]. Marc Lacroix has investigated the interrelationships between BCC and bone cells ([[osteoblast]]s, the bone-building cells, and [[osteoclast]]s, the bone-degrading cells). With colleagues, he discovered that BCC produce soluble factors increasing [[osteoclast]] activity, notably [[interleukin-11]], the production of which is reduced by the [[cyclooxygenase]] inhibitor [[aspirin]].<ref name="Lacroix5">{{cite journal | first=M | last= Lacroix | coauthors= Siwek B, Marie PJ, Body JJ. | title= Production and regulation of [[Interleukin 11|interleukin-11]] by breast cancer cells | journal= Cancer Letters | year=1998 | volume=127 |pages=29–35 | pmid=9619855 | doi= 10.1016/S0304-3835(97)00542-9 | issue=1–2}}</ref><ref name="Sotiriou1">{{cite journal | first=C | last= Sotiriou | coauthors= Lacroix M (co-first author), Lagneaux L, Berchem G, Body JJ. | title= The [[aspirin]] [[metabolite]] salicylate inhibits breast cancer cells growth and their synthesis of the osteolytic [[cytokine]]s interleukins-6 and-11 | journal= Anticancer Research | year=1999 | volume=19 |pages=2997–3006 | pmid=10652584 | issue=4B}}</ref><ref name="Sotiriou2">{{cite journal | first=C | last= Sotiriou | coauthors= Lacroix M, Lespagnard L, Larsimont D, Paesmans M, Body JJ. | title= Interleukins-6 and-11 expression in primary breast cancer and subsequent development of bone metastases | journal= Cancer Letters | year=2001 | volume=169 |pages=87–95 | pmid=11410329 | doi= 10.1016/S0304-3835(01)00524-9 | issue=1}}</ref> BCC also reduce the proliferation of osteoblasts and their production of collagen, the main protein component of bone.<ref name="Lacroix2">{{cite journal | first=M | last= Lacroix | coauthors= Siwek B, Body JJ.  | title= Effects of secretory products of breast cancer cells on [[osteoblast]]-like cells | journal= [[Breast Cancer Research and Treatment (journal)|Breast Cancer Research and Treatment]] | year=1996 | volume=38 |pages=209–216| pmid=8861839  | doi= 10.1007/BF01806675 | issue=2}}</ref><ref name="Siwek1">{{cite journal | first=B | last= Siwek | coauthors= Lacroix M, DePollak C, Marie P, Body JJ.  | title= Secretory products of breast cancer cells specifically affect human osteoblastic cells: Partial characterization of active factors | journal= Journal of Bone and Mineral Research | year=1997 | volume=12 |pages=552–560| pmid=9101366  | doi= 10.1359/jbmr.1997.12.4.552 | issue=4}}</ref><ref name="Lacroix6">{{cite journal | first=M | last= Lacroix | coauthors= Lacroix M, Marie PJ, Body JJ. | title= Protein production by osteoblasts: modulation by breast cancer cell-derived factors | journal= [[Breast Cancer Research and Treatment (journal)|Breast Cancer Research and Treatment]] | year=2000 | volume=61 |pages=59–67 | pmid=10930090 | doi= 10.1023/A:1006408916224 | issue=1}}</ref> Marc Lacroix also examined the response BCC to the anti-osteolytic agent [[calcitonin]]<ref name="Lacroix3">{{cite journal | first=M | last= Lacroix | coauthors= Body JJ.  | title= Regulation of [[C-Fos|c-fos]] and c-jun expression by [[calcitonin]] in human breast cancer cells | journal= Calcified Tissue International | year=1997 | volume=60 |pages=513–519| pmid=9164825  | doi= 10.1007/s002239900273 | issue=6}}</ref><ref name="Lacroix4">{{cite journal | first=M | last= Lacroix | coauthors= Siwek B, Body JJ.  | title= Breast cancer cell response to [[calcitonin]]: Modulation by growth-regulating agents | journal= European Journal of Pharmacology | year=1998 | volume=344 |pages=279–286| pmid=9600664  | doi= 10.1016/S0014-2999(97)01578-1 | issue=2–3}}</ref>

In close collaboration with Prof. Guy Leclercq (Laboratoire Jean-Claude Heuson de Cancérologie Mammaire, [[Institut Jules Bordet]], Belgium), Marc Lacroix has studied various aspects of [[estrogen receptor]] biology, ligand-binding and [[Transcription (genetics)|transcriptional]] activity, and life-cycle.<ref name="Jin1">{{cite journal | first=L | last= Jin | coauthors= Borras M, Lacroix M, Legros N, Leclercq G.  | title= Antiestrogenic activity of 2 11-beta-estradiol derivatives on MCF-7 breast cancer cells  | journal= [[Steroids]] | year=1995 | volume=60 |pages=512–518| pmid=8539793  | doi= 10.1016/0039-128X(95)00079-6 | issue=8}}</ref><ref name="Borras1">{{cite journal | first=M | last= Borras | coauthors= Lacroix M, Legros N, Leclercq G.  | title= [[Estrogen receptor]]-negative/progesterone receptor-positive Evsa-T mammary tumor cells: a model for assessing the biological property of this peculiar [[phenotype]] of breast cancers | journal= Cancer Letters | year=1997 | volume=120 |pages=23–30| pmid=9570382  | doi= 10.1016/S0304-3835(97)00285-1 | issue=1}}</ref><ref name="Maaroufi1">{{cite journal | first=Y | last= Maaroufi | coauthors= Lacroix M, Lespagnard L, Journe F, Larsimont D, Leclercq G. | title= Estrogen receptor of primary breast cancers: evidence for intracellular proteolysis | journal= Breast Cancer Research | year=2000 | volume=2 |pages=444–454 | pmid=11056692 | doi= 10.1186/bcr92 | issue=6 | pmc=13922}}</ref><ref name="Lacroix7">{{cite journal | first=M | last= Lacroix | coauthors= Querton G, Hennebert P, Larsimont D, Leclercq G. | title= Estrogen receptor analysis in primary breast tumors by ligand-binding assay, immmocytochemical assay, and northern blot: a comparison | journal= [[Breast Cancer Research and Treatment (journal)|Breast Cancer Research and Treatment]] | year=2001 | volume=67 |pages=263–271 | pmid=11561772 | doi= 10.1023/A:1017946810277 | issue=3}}</ref><ref name="Rivas2">{{cite journal | first=A | last= Rivas | coauthors= Lacroix M, Olea-Serrano F, Laios I, Leclercq G, Olea N. | title= Estrogenic effect of a series of bisphenol analogues on gene and protein expression in  MCF-7 breast cancer cells | journal= Journal of Steroid Biochemistry and Molecular Biology | year=2002 | volume=82 |pages=45–53 | pmid=12429138 | doi= 10.1016/S0960-0760(02)00146-2 | issue=1}}</ref><ref name="Lacroix10">{{cite journal | first=M | last= Lacroix | coauthors= Leclercq G. | title= About GATA3, HNF3A, and XBP1, three genes co-expressed with the oestrogen receptor-alpha gene (ESR1) in breast cancer | journal= Molecular and Cellular Endocrinology | year=2004 | volume=219 |pages=1–7 | pmid=15149721 | doi= 10.1016/j.mce.2004.02.021 | issue=1–2}}</ref><ref name="Toillon1">{{cite journal | first=RA | last=Toillon | coauthors= Magné N, Laios I, Lacroix M, Duvillier H, Lagneaux L, Devriendt D, Van Houtte P, Leclercq G. | title= Interaction between estrogen receptor alpha, ionizing radiation and (anti-) estrogens in breast cancer cells | journal= [[Breast Cancer Research and Treatment (journal)|Breast Cancer Research and Treatment]] | year=2005 | volume=93 |pages=207–215 | pmid=16136271 | doi= 10.1007/s10549-005-5148-0 | issue=3}}</ref><ref name="Leclercq1">{{cite journal | first=G | last=Leclercq | coauthors= Lacroix M, Laïos I, Laurent G. | title= Estrogen receptor alpha: impact of ligands on intracellular shuttling and turnover rate in breast cancer cells | journal= Current Cancer Drug Targets | year=2006 | volume=6 |pages=39–64 | pmid=16475975 | doi= 10.2174/156800906775471716 | issue=1}}</ref><ref name="Toillon2">{{cite journal | first=RA | last=Toillon | coauthors=Magné N, Laïos I, Castadot P, Kinnaert E, Van Houtte P, Desmedt C, Leclercq G, Lacroix M. | title= Estrogens decrease gamma-rays induced senescence and maintain cell cycle progression in breast cancer cells independently of p53 | journal= International Journal of Radiation Oncology, Biology, Physics | year=2007 | volume=67 |pages=1187–1200 | pmid=17336220 | issue=4 | doi=10.1016/j.ijrobp.2006.11.040}}</ref>

== Recent work ==
The amount of data on breast cancer available for the scientific and medical community is growing rapidly. According to [[PubMed]], a search engine offering access to the [[MEDLINE]] [[bibliographic database|database]] of citations and abstracts of biomedical research articles, 7918 papers containing the expression «breast cancer» were published in 2006. Their number was 3592 in 1996, 1455 in 1986 and only 626 in 1976.  In general, the older information is overlayed by more recent data and forgotten to some extent. In 2004, Lacroix and colleagues collected and assembled data from hundreds of articles related to the [[biology]], [[pathology]] and [[genetics]] of ''in situ'', invasive and [[metastasis|metastatic]] breast cancers. These papers were covering a time period of about 25 years. Lacroix ''et al.'' concluded that despite undergoing increasing genetic alteration, most individual breast cancers rather surprisingly maintain their [[phenotype]] when they evolve from ''in situ'' to the [[metastasis|metastatic]] state.<ref name="Lacroix11">{{cite journal | first=M | last= Lacroix | coauthors= Toillon RA, Leclercq G. | title= Stable 'portrait' of breast tumors during progression: data from biology, pathology and genetics | journal= Endocrine-Related Cancer | year=2004 | volume=11 |pages=497–522 | pmid=15369451 | doi= 10.1677/erc.1.00758 | issue=3}}</ref> This conclusion was in opposition to a progression model widely accepted at that time, which was suggesting that [[carcinoma]] ''[[in situ]]'' could evolve into invasive [[carcinoma]] and subsequently produce [[metastasis|metastases]] through an accumulation of molecular abnormalities possibly allowing extensive [[phenotype]] changes and subsequent gain of aggressiveness.

==Bibliography: articles in scientific and medical journals (excerpt)==
{{reflist}}

== Bibliography: invited chapters in thematic books ==
* Leclercq G, Lacroix M, Seo HS, Larsimont D. "Mechanisms regulating oestrogen receptor alpha expression in breast cancer.", in "Molecular Mechanisms of Action of Steroid Hormone Receptors" 65–75 (2002). Editors: Marija Krstic-Demonacos & Constantinos Demonacos, Research Signpost Publishers, Trivandrum, India, ISBN 81-7736-129-5, http://www.ressign.com/

*{{cite book |editor=Andrew P. Yao (ed.) |last=Lacroix |first=Marc |coauthors=Guy Leclercq |title=Focus on Breast Cancer Research |publisher=Nova Science Publishers |location=Commack, N.Y |year=2004 |pages=131–182 |chapter=An Updated View on Cell Lines as in Vitro Models for Breast Tumors |chapterurl=https://www.novapublishers.com/catalog/product_info.php?products_id=1822  |url=https://www.novapublishers.com/catalog/product_info.php?products_id=593 |isbn=1-59033-961-4 |accessdate=2008-07-17}}

* Sotiriou  C, Desmedt C, Durbecq V, Dal Lago L, Lacroix M, Cardoso F, Piccart M. "Genomic and molecular classification of breast cancer.", in "Molecular Oncology of Breast Cancer"  81–95 (2004). Editors: Jeffrey S. Ross and Gabriel N. Hortobagy, Jones and Bartlett Publishers, 40 Tall Pine Drive, Sudbury, MA 01776 USA, ISBN 0-7637-4810-2, http://www.jbpub.com/catalog/0763748102/table_of_contents.htm

*{{cite book |editor=Andrew P. Yao (ed.) |first=Marc |last=Lacroix |coauthors=Guy Leclercq |chapter=Hereditary Breast Cancer: An Update on Genotype and Phenotype |title=New Breast Cancer Research (Horizons in Cancer Research) |publisher=Nova Science Publishers |location=Commack, N.Y |year=2006 |pages=27–51 |isbn=1-59454-932-X |url=https://www.novapublishers.com/catalog/product_info.php?products_id=4134 |accessdate=2008-07-17}}

*{{cite book |editor=Katherine R. Polinsky (ed.) |first=Marc |last=Lacroix |chapter=An Update on Tumor Suppressor Genes in Breast Cancer |title=Tumor Suppressor Genes |publisher=Nova Science Publishers |location=Commack, N.Y |year=2007 |pages=177–256 |isbn=1-60021-693-5 |url=https://www.novapublishers.com/catalog/product_info.php?products_id=5679 |accessdate=2009-10-11}}

*{{cite book |editor=Akira Watanabe (ed.) |first=Marc |last=Lacroix |chapter=Disseminated Tumor Cells: Detection, Markers and Prognostic/Predictive Significance |title=Cancer Metastases Research Progress |publisher=Nova Science Publishers |location=Commack, N.Y |year=2008 |pages=1–45 |isbn=978-1-60456-130-2 |url=https://www.novapublishers.com/catalog/product_info.php?products_id=6621 |accessdate=2009-10-11}}

*{{cite book |editor=Martin E. Romero and Louis M. Dashek (ed.) |first=Marc |last=Lacroix |chapter=MicroRNAs in Breast Cancer  |title=Breast Cancer: Causes, Diagnosis and Treatment |publisher=Nova Science Publishers |location=Commack, N.Y |year=2010 |pages=1–53 |isbn=978-1-60876-463-1 |url=https://www.novapublishers.com/catalog/product_info.php?products_id=11609 |accessdate=2010-11-29}}

*{{cite book |editor=Eileen C. Roswell (ed.) |first=Marc |last=Lacroix |chapter=MicroRNAs in Breast Cancer  |title=Encyclopedia of Breast Cancer Research |publisher=Nova Science Publishers |location=Commack, N.Y |year=2011 |pages=? |isbn=978-1-61324-388-6 |url=https://www.novapublishers.com/catalog/product_info.php?products_id=23872 |accessdate=3 March 2011}}

== Bibliography: books ==
* Lacroix M. Tumor suppressor genes in breast cancer (2008). Nova Science Publishers, Inc, 400 Oser Ave, Ste 1600, Hauppauge, NY 11788-3635 USA, https://www.novapublishers.com/catalog/product_info.php?products_id=6866, ISBN 978-1-60456-326-9
* Lacroix M. Molecular therapy of breast cancer: classicism meets modernity (2009). Nova Science Publishers, Inc, 400 Oser Ave, Ste 1600, Hauppauge, NY 	11788-3635 USA, https://www.novapublishers.com/catalog/product_info.php?products_id=10042, ISBN 978-1-60741-593-0
* Lacroix M. MicroRNAs in breast cancer (2010). Nova Science Publishers, Inc, 400 Oser Ave, Ste 1600, Hauppauge, NY 11788-3635 USA, https://www.novapublishers.com/catalog/product_info.php?products_id=12776, ISBN 978-1-61668-438-9
* Lacroix M. A concise history of breast cancer (2011, 2013). Nova Science Publishers, Inc, 400 Oser Ave, Ste 1600, Hauppauge, NY 11788-3635 USA, https://www.novapublishers.com/catalog/product_info.php?cPath=23_132_105&products_id=18309, ISBN 978-1-61122-305-7 (2011), https://www.novapublishers.com/catalog/product_info.php?products_id=40565&osCsid=eab93c77d43f686ab6e8108d41306b3c (2013)
* Lacroix M. Coding for disease: genes and cancer (2013). Nova Science Publishers, Inc, 400 Oser Ave, Ste 1600, Hauppauge, NY 11788-3635 USA, https://www.novapublishers.com/catalog/product_info.php?products_id=41346, ISBN 978-1-62257-817-7

==References==
Over the years, Marc Lacroix has been refereeing for several international scientific and clinical journals:
* Acta Pharmacologica Sinica
* African Journal of Pharmacy and Pharmacology
* Anticancer Drugs
* [[BioEssays]]
* [[BioTechniques]]
* [[BMC Cancer]]
* [[BMC Microbiology]]
* Breast Cancer Research
* [[Breast Cancer Research and Treatment (journal)|Breast Cancer Research and Treatment]]
* Breast Disease
* [[British Journal of Cancer]]
* Cancer Cell International
* [[Cancer Investigation]]
* [[Cancer Research (journal)|Cancer Research]]
* Cancer Therapy
* [[Clinical Breast Cancer]]
* [[Clinical Cancer Research]]
* [[Clinical Chemistry (journal)|Clinical Chemistry]]
* Endocrine-Related Cancer
* Experimental Biology and Medicine
* [[Gene_(journal)|Gene]]
* [[International Journal of Cancer]]
* International Journal of Radiation Oncology, Biology, Physics
* [[In Vitro Cellular & Developmental Biology – Animal]]
* Journal of Cellular and Molecular Medicine
* Journal of Plant Breeding and Crop Science
* Medical Principles and Practice
* Medicinal Chemistry
* Molecular Cancer Therapeutics
* [[Molecules (journal)|Molecules]]
* [[Nature Protocols]]
* [[Oncogene (journal)|Oncogene]]
* Pharmacogenomics
* [[PLoS ONE]]
* The Breast

== External links ==
*Free access to [http://www.geocities.ws/m.lacroix/bcrt4.pdf "Relevance of breast cancer cell lines as models for breast tumours: an update"]
*Free access to [http://www.ulb.ac.be/di/map/bhaibeka/papers/lacroix2004gene.pdf "Gene regulation by phorbol 12-myristate 13-acetate in MCF-7 and MDA-MB-231, two breast cancer cell lines exhibiting highly different phenotypes"]
*Free access to [http://breast-cancer-research.com/content/pdf/bcr92.pdf "Estrogen receptor of primary breast cancers: evidence for intracellular proteolysis"]
*Free access to [http://erc.endocrinology-journals.org/cgi/reprint/11/3/497.pdf "Stable 'portrait' of breast tumors during progression: data from biology, pathology and genetics"]
*Free access to [http://erc.endocrinology-journals.org/cgi/reprint/13/2/293.pdf "P53 and breast cancer, an update"]
*Free access to [http://onlinelibrary.wiley.com/doi/10.1002/ijc.23233/pdf "Persistent use of ‘‘false’’ cell lines"]
*Free access to [http://erc.endocrinology-journals.org/cgi/reprint/13/4/1033.pdf "Significance, detection and markers of disseminated breast cancer cells"]
*Free access to [http://books.google.com/books?id=WsGHSmisaQIC&pg=PA1&dq=marc+lacroix+cancer&hl=en&ei=0s2dTMWNKpaSjAefuZWfDQ&sa=X&oi=book_result&ct=result&resnum=2&ved=0CC4Q6AEwAQ#v=onepage&q=marc%20lacroix%20cancer&f=false "Disseminated tumor cells: detection, markers and prognostic/predictive significance"]
*Free access to [http://books.google.be/books?id=HXu7Y5RPF30C&pg=PA27&dq=marc+lacroix+cancer&hl=fr&ei=aE_ITJv_AcuhOvSUiPAI&sa=X&oi=book_result&ct=result&resnum=4&ved=0CD8Q6AEwAw#v=onepage&q=marc%20lacroix%20cancer&f=false "Hereditary breast cancer: an update on genotype and phenotype"]
*Free access to [http://onlinelibrary.wiley.com/doi/10.1002/(SICI)1097-0215(19980529)76:5%3C677::AID-IJC11%3E3.0.CO;2-1/pdf "Establishment and characterization of three new breast-cancer cell lines"]
*Free access to [http://www.oocities.org/hotsprings/spa/3430/ccdt1.pdf "Estrogen Receptor Alpha: Impact of Ligands on Intracellular Shuttling and Turnover Rate in Breast Cancer Cells"]
*[http://www.ulb.ac.be/rech/inventaire/chercheurs/2/CH7042.html Université libre de Bruxelles – Marc Lacroix]

{{Persondata <!-- Metadata: see [[Wikipedia:Persondata]]. -->
| NAME              = Lacroix, Marc
| ALTERNATIVE NAMES =
| SHORT DESCRIPTION = biochemist, researcher
| DATE OF BIRTH     = 1963-04-28
| PLACE OF BIRTH    = Verviers, Belgium
| DATE OF DEATH     =
| PLACE OF DEATH    =
}}{{Use dmy dates|date=February 2013}}
{{DEFAULTSORT:Lacroix, Marc}}
[[Category:1963 births]]
[[Category:Living people]]
[[Category:People from Verviers]]
[[Category:Walloon people]]
[[Category:Belgian academics]]
[[Category:Belgian scientists]]
[[Category:Belgian biochemists]]
[[Category:Cancer researchers]]
[[Category:University of Liège alumni]]